Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure

被引:102
|
作者
Gumusoglu, Serena B. [1 ]
Chilukuri, Akanksha S. S. [1 ]
Santillan, Donna A. [2 ]
Santillan, Mark K. [2 ]
Stevens, Hanna E. [1 ]
机构
[1] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA
关键词
REDUCED UTERINE PERFUSION; AUTISM-SPECTRUM DISORDER; MATERNAL HYPERTENSIVE DISORDERS; FETAL-GROWTH RESTRICTION; NORMAL ANXIETY-LIKE; OXIDATIVE STRESS; CHILDREN BORN; PLACENTAL INSUFFICIENCY; COGNITIVE FUNCTION; BLOOD-PRESSURE;
D O I
10.1016/j.tins.2020.02.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Preeclampsia is a dangerous hypertensive disorder of pregnancy with known links to negative child health outcomes. Here, we review epidemiological and basic neuroscience work from the past several decades linking prenatal preeclampsia to altered neurodevelopment. This work demonstrates increased rates of neuropsychiatric disorders [e.g., increased autism spectrum disorder, attention deficit hyperactivity disorder (ADHD)] in children of preeclamptic pregnancies, as well as increased rates of cognitive impairments [e.g., decreased intelligence quotient (IQ), academic performance] and neurological disease (e.g., stroke and epilepsy). We also review findings from multiple animal models of preeclampsia. Manipulation of key clinical preeclampsia processes in these models (e.g., placental hypoxia, immune dysfunction, angiogenesis, oxidative stress) causes various disruptions in offspring, including ones in white matter/glia, glucocorticoid receptors, neuroimmune outcomes, cerebrovascular structure, and cognition/behavior. This animal work implicates potentially high-yield targets that may be leveraged in the future for clinical application.
引用
收藏
页码:253 / 268
页数:16
相关论文
共 50 条
  • [32] NEURODEVELOPMENTAL EFFECTS OF PRENATAL EXPOSURE TO PSYCHOTROPIC MEDICATIONS
    Gentile, Salvatore
    DEPRESSION AND ANXIETY, 2010, 27 (07) : 675 - 686
  • [33] PRENATAL EXPOSURE TO PESTICIDES AND NEURODEVELOPMENTAL DISORDERS IN CHILDREN
    Fage-Larsen, Bettina
    Andersen, Helle Raun
    Bilenberg, Niels
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S229 - S229
  • [34] Prenatal cocaine exposure and prematurity: Neurodevelopmental growth
    Espy, KA
    Francis, DJ
    Riese, ML
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2000, 21 (04): : 262 - 270
  • [35] PRENATAL EXPOSURE TO TERATOGENIC AGENTS AND NEURODEVELOPMENTAL OUTCOME
    ADAMS, J
    RESEARCH IN INFANT ASSESSMENT, 1989, 25 : 63 - 72
  • [36] Neurodevelopmental Trajectories Following Prenatal Alcohol Exposure
    Moore, Eileen M.
    Xia, Yingjing
    FRONTIERS IN HUMAN NEUROSCIENCE, 2022, 15
  • [37] Neurodevelopmental outcome after prenatal exposure to opiates
    Bunikowski, R
    Grimmer, I
    Heiser, A
    Metze, B
    Schäfer, A
    Obladen, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (09) : 724 - 730
  • [38] Prenatal Intravenous Magnesium and Neurodevelopmental Outcomes in Offspring
    Marret, Stephane
    Chollat, Clement
    Sentilhes, Loic
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (23):
  • [39] Infant and Childhood Neurodevelopmental Outcomes Following Prenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs)
    Malm, Heli
    Artama, Miia
    Brown, Alan S.
    Gissler, Mika
    Gyllenberg, David
    Hinkka-Yli-Salomaki, Susanna
    McKeague, Ian
    Sourander, Andre
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 141 - 142
  • [40] BEHAVIORAL, NEURODEVELOPMENTAL, COGNITIVE, LANGUAGE, AND MEDICAL OUTCOMES OF PRENATAL OPIOID EXPOSURE ON CHILDREN: A SCOPING REVIEW
    Liaqat, Sumbul
    Shahab, Muhammad Hamza
    Ashraf, Nauman
    Alkhafaji, Raghad
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S175 - S175